NARCRMS Reaches Enrollment Milestone

This content is courtesy of The Consortium of Multiple Sclerosis Centers.

(Hackensack, NJ, March 2020) -- The North American Registry for Care and Research in MS (NARCRMS) is pleased to announce enrollment of its 700^th patient on Wednesday, February 26, 2020. NARCRMS anticipates enrolling up to 1,250 patients across 30 sites in the US and Canada. The registry is committed to recruiting patients of diverse ethnic and racial backgrounds, with over 150 Hispanic patients and approximately 75 patients that self-identify as Black or African American enrolled to date.

The mission of NARCRMS is to provide clinicians and researchers with a greater, more integrated ability to track the incidence, prevalence and course of multiple sclerosis. Through information sharing, the registry seeks to improve the understanding of MS and facilitate care at every level. NARCRMS is unique as the first open source MS registry in the US and Canada that provides de-identified data to all stakeholders.

NARCRMS is a highly collaborative effort involving other MS registries, clinicians, researchers, and people living with MS and is endorsed by the National Multiple Sclerosis Society.

CMSC is the leading educational, training, and networking organization for MS healthcare professionals, researchers and professionals in training. The mission of CMSC is to promote high quality MS care through educational programming and accreditation including live and online events, research grants, technical journals and papers, and targeted advocacy efforts. The CMSC member network includes more than 12,000 international healthcare clinicians and scientists committed to MS care as well as more than 60 Veterans Administration MS Programs and 250 MS Centers in the US, Canada, and Europe.

Learn more about NARCRMS and CMSC at the 34^rd CMSC Annual Meeting, the leading research and educational conference for MS healthcare professionals in North America. Taking place May 27 — 30, 2020, in Orlando, FL, the CMSC Annual Meeting has a full agenda of lectures, symposia, courses, and roundtables as well as poster and platform presentations that will enhance professional practice and improve treatment outcomes in multiple sclerosis.

For more information visit: www.narcrms.org or http://www.mscare.org/2020